A Phase 1 study of Dihydromyricetin in healthy volunteers

Not Yet Recruiting Phase 1 NCT05623501

Study Description

A study to evaluate the safety, dosing, and blood levels of Dihydromyricetin (DHM) in healthy volunteers

Study Details

Registry ID:: NCT05623501
Conditions:: Alcohol-Related Disorders
Phase:: Phase 1
Target Enrollment:: 12 participants
Start Date:: September 15, 2024
Age Range:: 18–60 years
Healthy Volunteers:: No

Study Locations (1 site)

University of Southern California
Los Angeles, CaliforniaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →